<DOC>
	<DOCNO>NCT01329224</DOCNO>
	<brief_summary>The purpose study investigate incidence acetylsalicylic acid resistance ( ASA-R ) among patient chronic acetylsalicylic acid ( ASA ) treatment see outpatient clinic .</brief_summary>
	<brief_title>The Antiaggregation Monitoring ( TAM ) Registry</brief_title>
	<detailed_description>Acetylsalicylic acid ( ASA ) resistance ( R ) best define ineffective inhibition platelet cyclooxygenase ( COX ) -1 pathway , report 1 61 % patient treat ASA . Impaired response ASA associate increase risk ischemic event patient know coronary artery disease . We seek investigate incidence ASA-R clinical practice . All consecutive patient chronic ASA treatment ( 100mg/d ) see outpatient clinic systematically include registry . All patient acetylsalicylic acid CAD least 1 month . Patients inform ASA test start consultation outpatient clinic . Eligible patient provide write informed consent . Peripheral venous blood sample analyze use whole blood impedance platelet aggregometry Multiplate analyzer . The Multiplate analyzer device allow measure platelet aggregation attachment platelet two silver coat copper electrode lead rise electrical resistance sample . The measurement express arbitrary aggregation unit ( AU ) manufacturer define cutoff use : normal value 76-136 AU , partial antiaggregation define ASA value 31 75 AU complete antiaggregation define ASA value &lt; 31 AU .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>patient chronic ASA treatment one month concomitant use nonsteroidal antiinflammatory drug ( NSAIDs ) thrombocytopenia thrombocytosis age &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>acetylsalicylic acid resistance</keyword>
</DOC>